Teva launches generic Delzicol in U.S.

|About: Allergan plc (AGN)|By:, SA News Editor

Teva Pharmaceutical Industries (TEVA -1.9%) launches its generic version of Allergan's (AGN -1.7%) ulcerative colitis med Delzicol (mesalamine) delayed-release capsules, 400 mg in the U.S.

Per IQVIA, the U.S. market is ~$130M.

Subscribe for full text news in your inbox